These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Russo AA; Tong L; Lee JO; Jeffrey PD; Pavletich NP Nature; 1998 Sep; 395(6699):237-43. PubMed ID: 9751050 [TBL] [Abstract][Full Text] [Related]
3. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a. Baumgartner R; Fernandez-Catalan C; Winoto A; Huber R; Engh RA; Holak TA Structure; 1998 Oct; 6(10):1279-90. PubMed ID: 9782052 [TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d. Brotherton DH; Dhanaraj V; Wick S; Brizuela L; Domaille PJ; Volyanik E; Xu X; Parisini E; Smith BO; Archer SJ; Serrano M; Brenner SL; Blundell TL; Laue ED Nature; 1998 Sep; 395(6699):244-50. PubMed ID: 9751051 [TBL] [Abstract][Full Text] [Related]
5. Lack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis. Bartkova J; Thullberg M; Rajpert-De Meyts E; Skakkebaek NE; Bartek J Oncogene; 2000 Aug; 19(36):4146-50. PubMed ID: 10962575 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule. Fåhraeus R; Laín S; Ball KL; Lane DP Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104 [TBL] [Abstract][Full Text] [Related]
7. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Said TK; Medina D Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257 [TBL] [Abstract][Full Text] [Related]
8. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1. Phelps DE; Xiong Y Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177 [TBL] [Abstract][Full Text] [Related]
9. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development. Zindy F; Soares H; Herzog KH; Morgan J; Sherr CJ; Roussel MF Cell Growth Differ; 1997 Nov; 8(11):1139-50. PubMed ID: 9372237 [TBL] [Abstract][Full Text] [Related]
10. Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases. Okuda T; Hirai H; Valentine VA; Shurtleff SA; Kidd VJ; Lahti JM; Sherr CJ; Downing JR Genomics; 1995 Oct; 29(3):623-30. PubMed ID: 8575754 [TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C). Yuan C; Li J; Selby TL; Byeon IJ; Tsai MD J Mol Biol; 1999 Nov; 294(1):201-11. PubMed ID: 10556039 [TBL] [Abstract][Full Text] [Related]
12. Ubiquitin/proteasome-mediated degradation of p19INK4d determines its periodic expression during the cell cycle. Thullberg M; Bartek J; Lukas J Oncogene; 2000 Jun; 19(24):2870-6. PubMed ID: 10851091 [TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor INK4: determination of the solution structure of p18INK4C and demonstration of the functional significance of loops in p18INK4C and p16INK4A. Li J; Byeon IJ; Ericson K; Poi MJ; O'Maille P; Selby T; Tsai MD Biochemistry; 1999 Mar; 38(10):2930-40. PubMed ID: 10074345 [TBL] [Abstract][Full Text] [Related]
14. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells. Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932 [TBL] [Abstract][Full Text] [Related]
15. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6. Noh SJ; Li Y; Xiong Y; Guan KL Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity. Schreiber M; Muller WJ; Singh G; Graham FL Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428 [TBL] [Abstract][Full Text] [Related]
17. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras. Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827 [TBL] [Abstract][Full Text] [Related]
18. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Lukas J; Parry D; Aagaard L; Mann DJ; Bartkova J; Strauss M; Peters G; Bartek J Nature; 1995 Jun; 375(6531):503-6. PubMed ID: 7777060 [TBL] [Abstract][Full Text] [Related]
19. The p19INK4D cyclin dependent kinase inhibitor gene is altered in osteosarcoma. Miller CW; Yeon C; Aslo A; Mendoza S; Aytac U; Koeffler HP Oncogene; 1997 Jul; 15(2):231-5. PubMed ID: 9244358 [TBL] [Abstract][Full Text] [Related]
20. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Serrano M; Hannon GJ; Beach D Nature; 1993 Dec; 366(6456):704-7. PubMed ID: 8259215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]